Carmen M Craven, NP
Nurse Practitioner · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 9 years
- Graduated 2017
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Carmen M Craven’s office at (415) 600-1020 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$10,219
Medicare paid this office $10,219 for 74 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 17 | $4,780 | None |
| Aspiration and/or injection of fluid from large joint | 46 | $3,477 | $50 |
| Short return visit (20+ min) | 17 | $914 | $51 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 47 | $258 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 126 | 157 | 157 | 124 | 189 | 70 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
74 Original Medicare patients in 2024. Average age 75 · Women 65% · Health risk score 0.93. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 57% · Depression 23% · Atrial fibrillation 20% · Cancer 18% · Coronary heart disease 15%.
The office billed $56,539, Medicare allowed $15,603 and paid $10,219; for 541 services of 7 kinds; $5,038 of it was for drugs given in the office and $5,181 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 74 | 541 | 75 | 0.93 | $56,539 | $10,219 |
| 2023 | 124 | 987 | 75 | 0.77 | $143,907 | $31,925 |
| 2022 | 72 | 538 | 76 | 0.77 | $94,452 | $22,293 |
| 2021 | 97 | 637 | 77 | 0.86 | $133,343 | $28,024 |
| 2020 | 95 | 673 | 77 | 0.82 | $127,112 | $25,472 |
| 2019 | 88 | 407 | 76 | 0.88 | $97,435 | $28,941 |
| 2018 | 57 | 247 | 73 | 0.80 | $59,017 | $12,287 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 55 | $14,725 | None |
| Aspiration and/or injection of fluid from large joint | 100 | $11,257 | $60 |
| Short return visit (20+ min) | 21 | $1,668 | $69 |
| Short return visit | 11 | $580 | $41 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | $490 | None |
2022: 4 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 34 | $10,249 | None |
| Aspiration and/or injection of fluid from large joint | 62 | $6,966 | $56 |
| Short return visit (20+ min) | 17 | $1,218 | $72 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $250 | None |
2021: 4 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 49 | $13,011 | None |
| Aspiration and/or injection of fluid from large joint | 73 | $8,494 | $54 |
| Short return visit (20+ min) | 28 | $2,300 | $74 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 31 | $286 | None |
2020: 5 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 54 | $12,940 | None |
| Aspiration and/or injection of fluid from large joint | 76 | $7,847 | $50 |
| Short return visit | 33 | $1,402 | $39 |
| Short return visit (20+ min) | 18 | $942 | $52 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 35 | $367 | None |
2019: 4 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 41 | $19,208 | None |
| Aspiration and/or injection of fluid from large joint | 72 | $6,241 | $50 |
| Short return visit (20+ min) | 39 | $2,810 | $59 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 38 | $163 | None |
2018: 4 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 27 | $6,452 | None |
| Aspiration and/or injection of fluid from large joint | 50 | $3,905 | $51 |
| Short return visit (20+ min) | 22 | $1,357 | $59 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 26 | $100 | None |
Drugs they prescribed that Part D paid
$4,190
Pharmacies billed $4,190 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 37% of their Part D prescriptions (103 of 277) in 2024. A higher opioid share than 9 in 10 peers; the typical nurse practitioner clinician is at 0%.
276 generic and fewer than 11 brand-name prescriptions · $4,190 in drug cost · 58 antibiotic prescriptions to 58 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Clindamycin Phosphate | 44 | $1,216 | $28 |
| Oxycodone-Acetaminophen | 57 | $1,002 | $18 |
| Doxycycline Hyclate | 56 | $861 | $15 |
| Diclofenac | 13 | $360 | $28 |
| Hydrocodone-Acetaminophen | 25 | $224 | $9 |
See all 7 drugs
| Clindamycin Phosphate | 44 | $1,216 | $28 |
| Oxycodone-Acetaminophen | 57 | $1,002 | $18 |
| Doxycycline Hyclate | 56 | $861 | $15 |
| Diclofenac | 13 | $360 | $28 |
| Hydrocodone-Acetaminophen | 25 | $224 | $9 |
| Ibuprofen | 16 | $99 | $6 |
| Ondansetron | 11 | $35 | $3 |
Year by year
| 2024 | 277 | 117 | 37% (103) | None | $4,190 |
| 2023 | 481 | 177 | 39% (185) | None | $8,522 |
| 2022 | 423 | 164 | 37% (158) | None | $9,067 |
| 2021 | 462 | 173 | 39% (182) | None | $9,944 |
| 2020 | 410 | 123 | 37% (153) | None | $7,585 |
| 2019 | 323 | 142 | 54% (174) | None | $6,809 |
| 2018 | 216 | 115 | 67% (145) | None | $2,250 |
| 2017 | 18 | None | 94% (17) | 0% | $209 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Clindamycin Phosphate | 82 | $2,666 | $33 |
| Doxycycline Hyclate | 93 | $2,226 | $24 |
| Oxycodone-Acetaminophen | 114 | $1,557 | $14 |
| Hydrocodone-Acetaminophen | 27 | $289 | $11 |
| Gabapentin | 17 | $224 | $13 |
| Ondansetron | 26 | $184 | $7 |
| Ibuprofen | 21 | $146 | $7 |
| Tramadol | 27 | $104 | $4 |
| Zolpidem | 15 | $93 | $6 |
2022: 10 drugs
| Clindamycin Phosphate | 71 | $2,000 | $28 |
| Doxycycline Hyclate | 72 | $1,983 | $28 |
| Oxycodone-Acetaminophen | 113 | $1,941 | $17 |
| Hydrocodone-Acetaminophen | 25 | $296 | $12 |
| Ondansetron | 13 | $233 | $18 |
| Doxycycline Monohydrate | 22 | $168 | $8 |
| Ibuprofen | 17 | $146 | $9 |
| Zolpidem | 20 | $91 | $5 |
| Tramadol | 13 | $52 | $4 |
| Diazepam | 13 | $12 | $1 |
2021: 10 drugs
| Clindamycin Phosphate | 78 | $2,686 | $34 |
| Doxycycline Hyclate | 82 | $2,562 | $31 |
| Oxycodone-Acetaminophen | 117 | $2,030 | $17 |
| Hydrocodone-Acetaminophen | 32 | $398 | $12 |
| Diclofenac | 17 | $218 | $13 |
| Gabapentin | 15 | $155 | $10 |
| Ondansetron | 12 | $151 | $13 |
| Ibuprofen | 18 | $126 | $7 |
| Tramadol | 17 | $102 | $6 |
| Diazepam | 14 | $12 | $1 |
2020: 10 drugs
| Clindamycin Phosphate | 61 | $2,164 | $35 |
| Doxycycline Hyclate | 69 | $1,878 | $27 |
| Oxycodone-Acetaminophen | 94 | $1,405 | $15 |
| Diclofenac | 33 | $773 | $23 |
| Hydrocodone-Acetaminophen | 32 | $335 | $10 |
| Celecoxib | 15 | $318 | $21 |
| Tramadol | 23 | $102 | $4 |
| Zolpidem | 19 | $96 | $5 |
| Ibuprofen | 12 | $67 | $6 |
| Diazepam | 12 | $17 | $1 |
2019: 8 drugs
| Oxycodone-Acetaminophen | 114 | $1,223 | $11 |
| Doxycycline Hyclate | 29 | $1,037 | $36 |
| Hydrocodone-Acetaminophen | 24 | $198 | $8 |
| Gabapentin | 13 | $182 | $14 |
| Ibuprofen | 15 | $140 | $9 |
| Tramadol | 23 | $92 | $4 |
| Ondansetron | 13 | $91 | $7 |
| Zolpidem | 19 | $52 | $3 |
2018: 5 drugs
| Oxycodone-Acetaminophen | 97 | $1,299 | $13 |
| Hydrocodone-Acetaminophen | 29 | $245 | $8 |
| Gabapentin | 13 | $151 | $12 |
| Ibuprofen | 14 | $95 | $7 |
| Zolpidem | 16 | $88 | $6 |
Money from drug and device companies
$248 in 2023
| 2023 | 2 | 2 | None | $248 |
| 2022 | 3 | 3 | None | $343 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Qulipta | $126 | 1 payment
|
| Gilead Sciences | Epclusa | $123 | 1 payment
|
See all 2 published payments
| Gilead Sciences | Meals · 2023-08-23 | Epclusa | $123 |
| Abbvie | Meals · 2023-04-20 | Qulipta | $126 |
See earlier years (2022)
2022: $343
| Amgen | Repatha | $135 | 1 payment
|
| Ultragenyx Pharmaceutical | Crysvita | $119 | 1 payment
|
| Scynexis | None | $88 | 1 payment
|
Professional record
- NPI
- 1316462310
- Licence
- CA 95006633
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-08-10
- NPI last updated
- 2020-06-11
- NPI record certified
- 2020-06-11
This is when the NPI record was last certified, not a medical board exam.